OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity



Status:Terminated
Conditions:Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 80
Updated:4/21/2016
Start Date:May 2014
End Date:December 2015

Use our guide to learn which trials are right for you!

This is a safety and efficacy study of onabotulinumtoxinA in poststroke patients with upper
limb spasticity.


Inclusion Criteria:

- Upper limb spasticity in the elbow and shoulder due to stroke, with the most recent
stroke at least 3 months ago

Exclusion Criteria:

- Spasticity in the non-study upper limb that requires treatment

- Presence of fixed contractures in of the study muscles in elbow or shoulder

- Profound atrophy of muscles to be injected

- Previous surgical intervention, nerve block, or muscle block for the treatment of
spasticity in the study limb in the last 12 months

- Injection of corticosteroids or anesthetics, use of casting or dynamic splinting or
constraint-induced movement therapy (CIMT) for the study limb within 3 months

- Ultrasound therapy, electrical stimulation, or acupuncture in the study limb within 1
month

- Condition other than stroke contributing to upper limb spasticity

- Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, and/or amyotrophic lateral
sclerosis
We found this trial at
2
sites
?
mi
from
Overland Park, KS
Click here to add this to my saved trials
?
mi
from
Montreal,
Click here to add this to my saved trials